Xiao-Ning Xu mainly focuses on Immunology, Virology, T cell, CD8 and Fas ligand. Xiao-Ning Xu is involved in the study of Immunology that focuses on Antibody in particular. His study in Antibody is interdisciplinary in nature, drawing from both Pandemic and Immunity.
His research in Virology is mostly focused on Virus. His CD8 study improves the overall literature in Immune system. His Fas ligand research includes elements of Jurkat cells, Cell biology, Death domain and Fas receptor.
His main research concerns Virology, Immunology, Immune system, T cell and CD8. CTL*, Mutation and Allele is closely connected to Human leukocyte antigen in his research, which is encompassed under the umbrella topic of Virology. His Immunology research focuses on Viral load, Antibody, Monoclonal antibody, Immunity and Epitope.
He has included themes like Inflammation, Interferon and Cell biology in his Immune system study. His research in Cell biology intersects with topics in Jurkat cells, Natural killer T cell, CD1D, Molecular biology and Major histocompatibility complex. His research investigates the connection between T cell and topics such as Antigen that intersect with problems in Effector.
Xiao-Ning Xu focuses on Virology, Immunology, T cell, Viral load and Immune system. His Virology research integrates issues from Gene and High-throughput screening. His work in the fields of Immunology, such as Antibody, Vaccination, Hepatitis C and Hepatitis B, intersects with other areas such as Serum iron.
Antibody connects with themes related to Virus in his study. He works mostly in the field of T cell, limiting it down to concerns involving Human leukocyte antigen and, occasionally, CD8. The various areas that he examines in his Immune system study include Inflammation and Interferon.
The scientist’s investigation covers issues in Virology, Immunology, Viral load, Antibody and Vaccination. His research brings together the fields of Cohort and Virology. His Viral load research incorporates themes from Men who have sex with men, Acquired immunodeficiency syndrome, Cohort study and Confidence interval.
His studies in Antibody integrate themes in fields like T cell, Virus, Influenza vaccine, Antigen and Pandemic. His research on Virus often connects related areas such as Epitope. His Vaccination study integrates concerns from other disciplines, such as Psychological intervention, Epidemiology, Environmental health, Pneumonia and Intensive care medicine.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever.
Juthathip Mongkolsapaya;Wanwisa Dejnirattisai;Xiao-ning Xu;Sirijitt Vasanawathana.
Nature Medicine (2003)
Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans
T M Wilkinson;Li Ckf.;Chui Csc.;Huang Aky.;Huang Aky..
Nature Medicine (2012)
T Cell Responses to Whole SARS Coronavirus in Humans
Chris Ka Fai Li;Hao Wu;Huiping Yan;Shiwu Ma.
Journal of Immunology (2008)
TRICK2, a new alternatively spliced receptor that transduces the cytotoxic signal from TRAIL
Gavin R. Screaton;Juthathip Mongkolsapaya;Xiao-Ning Xu;Alison E. Cowper.
Current Biology (1997)
Induction of Fas ligand expression by HIV involves the interaction of Nef with the T cell receptor zeta chain.
Xiao-Ning Xu;Bernd Laffert;Gavin R. Screaton;Michael Kraft.
Journal of Experimental Medicine (1999)
T Cell Responses in Dengue Hemorrhagic Fever: Are Cross-Reactive T Cells Suboptimal?
Juthathip Mongkolsapaya;Thaneeya Duangchinda;Wanwisa Dejnirattisai;Sirijit Vasanawathana.
Journal of Immunology (2006)
LARD: a new lymphoid-specific death domain containing receptor regulated by alternative pre-mRNA splicing.
Gavin R. Screaton;Xiao Ning Xu;Anna L. Olsen;Alison E. Cowper.
Proceedings of the National Academy of Sciences of the United States of America (1997)
Evasion of Cytotoxic T Lymphocyte (CTL) Responses by Nef-dependent Induction of Fas Ligand (CD95L) Expression on Simian Immunodeficiency Virus–infected Cells
Xiao Ning Xu;Gavin R. Screaton;Frances M. Gotch;Tao Dong.
Journal of Experimental Medicine (1997)
Effect of previous SARS-CoV-2 infection on humoral and T-cell responses to single-dose BNT162b2 vaccine.
Maria Prendecki;Maria Prendecki;Candice Clarke;Jonathan Brown;Alison Cox.
The Lancet (2021)
Expression of TRAIL and TRAIL receptors in normal and malignant tissues
Raymond A Daniels;Helen Turley;Fiona C Kimberley;Xue Song Liu.
Cell Research (2005)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of Oxford
University of Oxford
Mahidol University
University of Oxford
National Science and Technology Development Agency
University of Sheffield
National Institute of Allergy and Infectious Diseases
University of Oxford
University of Oxford
University of Oxford
Rutgers, The State University of New Jersey
University of California, Irvine
University of Nottingham
United States Naval Research Laboratory
University of Rochester Medical Center
University of Cambridge
University of New South Wales
University of Edinburgh
University of Salamanca
Academia Sinica
Centers for Disease Control and Prevention
Max Planck Society
Geophysical Fluid Dynamics Laboratory
University of Leeds
University of California, Irvine
University of Bern